IP Library Granted Patent US 8,096,979
Granted Patent B2
US 8,096,979 · App. 12/491,419 · Granted Jan 17, 2012

Reduced pressure treatment system having a dual porosity pad

Assignee: KCI Licensing, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,096,979
App. No.
12/491,419
Granted
Jan 17, 2012
Kind
B2
Abstract

A wound closure system and method having a porous pad for providing a reduced pressure to a tissue site is disclosed. The porous pad comprises a porous material formed by spraying a chemical substance that cures to form the porous material which has a body and an outer surface. Both the body and the outer surface have pores wherein the average size of the pores in the outer surface is smaller than the average size of the pores in the body. The porous pad further comprises a pathway formed within the porous material that is adapted to fluidly communicate with a source of reduced pressure.

Claims (16)

1. A porous pad for providing a reduced pressure to a tissue site comprising:

a porous material formed by spraying a chemical substance that cures to form the porous material having a body and an outer surface, both the body and the outer surface having pores wherein the average size of the pores in the outer surface is smaller than the average size of the pores in the body, and a portion of the outer surface substantially conformable to the shape of the tissue site; and

a pathway formed within the porous material and adapted to fluidly communicate with a source of reduced pressure.

2. The pad of claim 1 , wherein the average size of the pores in the outer surface is about 100 microns or less in diameter.

3. The pad of claim 1 , wherein the chemical substance cures and hardens to form the porous material after spraying the chemical substance.

4. The pad of claim 1 , wherein the sprayed chemical substance expands to form the porous material after the chemical substance is sprayed.

5. The pad of claim 1 , wherein the porous material includes an antimicrobial agent.

6. The pad of claim 1 , wherein the chemical substance comprises a pressurized liquid before being sprayed and expels gas from the pressurized liquid when sprayed, whereby the chemical substance expands and hardens to form the porous material.

7. The pad of claim 1 , wherein the porous material is formed by spraying the chemical substance directly onto the tissue site.

8. The pad of claim 1 , wherein the porous material is formed by spraying the chemical substance onto a surface other than the tissue site.

9. A tissue treatment system comprising:

a porous material formed by spraying a chemical substance that cures to form the porous material having a body and an outer surface, both the body and the outer surface having pores wherein the average size of the pores in the outer surface is smaller than the average size of the pores in the body, and a portion of the outer surface substantially conformable to the shape of the tissue site;

a pathway formed within the porous material and adapted to fluidly communicate with a source of reduced pressure whereby reduced pressure is provided to the tissue site; and

a conduit operable to deliver the reduced pressure, a first end of the conduit being connectable to the pathway and a second end of the conduit being connectable to the source of reduced pressure.

10. The system of claim 9 , wherein the first end of the conduit extends into the porous material.

11. The system of claim 9 , further comprising a drape adapted to cover the porous material.

Assignments (5)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2014
From: LINA, CESAR Z.; HEATON, KEITH; JOHNSON, ROYCE
To: KCI LICENSING, INC.
Reel/Frame 032505/0177 →
Continuity (5)
Division 11803117 · May 11, 2007
Continuation 10600061 · Jun 20, 2003
Continuation 09545339 · Apr 7, 2000
Provisional Application 60128567 · Apr 9, 1999
Related Publication 20100022972A1 · Jan 28, 2010